Expert urologists from Columbia and Weill Cornell Medicine offer unparalleled services for patients with both common and complex urologic diseases and disorders, including significant experience and expertise in prostate, bladder, and other urologic cancers. Through clinical trials and basic research, our clinicians contribute to the development of novel diagnostics, new medications, and improved surgical techniques to optimize the lives of their patients.
Urology
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
Featured Updates
On this episode of Advances in Care, Erin Welsh is joined by Dr. Lawrence Lustig, chair of the Department of Otolaryngology – Head & Neck Surgery at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic hearing loss and after years of research his team was the first to show that gene therapies could be effective at reversing genetic hearing loss in mouse models and eventually, humans. In April 2026, the FDA approved the first ever gene therapy for genetic deafness based on the work pushed forward by Dr. Lustig.
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
